847 The Fully Human Anti-IL-15 Antibody AMG 714, in Development for Celiac and Refractory Celiac Disease, Does Not Reduce Circulating Numbers of Human Natural Killer Cells or Preclude Their In Vitro Activation and Function

MLA

Kevin S. Gorski, et al. “847 The Fully Human Anti-IL-15 Antibody AMG 714, in Development for Celiac and Refractory Celiac Disease, Does Not Reduce Circulating Numbers of Human Natural Killer Cells or Preclude Their In Vitro Activation and Function.” Gastroenterology, vol. 150, Apr. 2016, p. S180. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........267b74b09012091b7ffcc2c654b2fcff&authtype=sso&custid=ns315887.

APA

Kevin S. Gorski, Wayne Tsuji, Eric A. Butz, Francisco León, & Herve Lebrec. (2016). 847 The Fully Human Anti-IL-15 Antibody AMG 714, in Development for Celiac and Refractory Celiac Disease, Does Not Reduce Circulating Numbers of Human Natural Killer Cells or Preclude Their In Vitro Activation and Function. Gastroenterology, 150, S180.

Chicago

Kevin S. Gorski, Wayne Tsuji, Eric A. Butz, Francisco León, and Herve Lebrec. 2016. “847 The Fully Human Anti-IL-15 Antibody AMG 714, in Development for Celiac and Refractory Celiac Disease, Does Not Reduce Circulating Numbers of Human Natural Killer Cells or Preclude Their In Vitro Activation and Function.” Gastroenterology 150 (April): S180. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........267b74b09012091b7ffcc2c654b2fcff&authtype=sso&custid=ns315887.